Major shareholders
Biocartis Group NV’s shareholder structure, based on the most recent number of shares and transparency notifications of holdings in excess of 3%, is as follows:
SFPI-FPIM (1): 7.18%
JPMorgan Chase & Co (2): 5.26%
Johnson & Johnson Innovation – JJDC, Inc. (3): 4.11%
UBS Group AG (4): 4.49%
Other institutional and retail investors: 78.96%
Notes:
(1) SFPI-FPIM is 100% controlled by the Belgian State.
(2) JP Morgan Chase & Co
(3) Johnson & Johnson Innovation-JJDC, Inc., is a wholly owned subsidiary of Johnson & Johnson. Johnson & Johnson is not a controlled entity.
(4) UBS Group AG controls Credit Suisse AG, Credit Suisse (Schweiz) AG and Credit Suisse Asset Management International Holding Ltd, Credit Suisse Asset Management & Investor Services (Schweiz) Holding AG, Credit Suisse Fund Management S.A.
The Articles of the Association of BIOCARTIS GROUP NV provide for shareholders notification threshold of 3%, 5% or a multiple of 5% (i.e. 10%, 15%, 20% etc) of the total number of existing voting rights. The notification forms can be downloaded from the website of the FSMA. Completed and signed forms should be sent to info@biocartisgroupnv.be.
See hereunder a list of all transparency notifications press releases and transparency notifications forms received to date.